Extended Postexposure Protection Against Vaginal Simian/Human Immunodeficiency Virus Infection With Tenofovir Alafenamide Fumarate/Elvitegravir Inserts in Macaques
The Journal of Infectious Diseases · 2024
DOI: 10.1093/infdis/jiad599 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Natalia Makarova und 15 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Branch, Division of HIV Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and…. Hauptthemen laut MEDLINE: Tenofovir, Quinolones, Alanine, Simian Acquired Immunodeficiency Syndrome. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS, CDC HHS, Centers for Disease Control and Prevention.
Abstract (Originalsprache)
Vaginal inserts that can be used on demand before or after sex may be a desirable human immunodeficiency virus (HIV) prevention option for women. We recently showed that inserts containing tenofovir alafenamide fumarate (TAF, 20 mg) and elvitegravir (EVG, 16 mg) were highly protective against repeated simian/human immunodeficiency virus (SHIV) vaginal exposures when administered to macaques 4 hours before or after virus exposure (93% and 100%, respectively). Here, we show in the same macaque model that insert application 8 hours or 24 hours after exposure maintains high efficacy (94.4% and 77.2%, respectively). These data extend the protective window by TAF/EVG inserts and inform their clinical development for on-demand prophylaxis in women.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory Branch, Division of HIV Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
- CONRAD, Eastern Virginia Medical School, Norfolk, Virginia.
- Quantitative Sciences Branch, Division of HIV Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
ORCID-Profile: J Gerardo García-Lerma
Förderung
- Intramural CDC HHS
- CDC HHS
- Centers for Disease Control and Prevention
Zitieren
APA
Makarova, N., Singletary, T., Peet, M. M., Mitchell, J., Bachman, S., Holder, A., Dinh, C., Lipscomb, J., Agrahari, V., Mendoza, M., Pan, Y., Heneine, W., Clark, M. R., García-Lerma, J. G., Doncel, G. F., & Smith, J. M. (2024). Extended Postexposure Protection Against Vaginal Simian/Human Immunodeficiency Virus Infection With Tenofovir Alafenamide Fumarate/Elvitegravir Inserts in Macaques. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad599
Vancouver
Makarova N, Singletary T, Peet MM, Mitchell J, Bachman S, Holder A, et al. Extended Postexposure Protection Against Vaginal Simian/Human Immunodeficiency Virus Infection With Tenofovir Alafenamide Fumarate/Elvitegravir Inserts in Macaques. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiad599
BibTeX
@article{Makarova2024,
author = {Makarova, Natalia and Singletary, Tyana and Peet, M Melissa and Mitchell, James and Bachman, Shanon and Holder, Angela and Dinh, Chuong and Lipscomb, Jonathan and Agrahari, Vivek and Mendoza, Maria and Pan, Yi and Heneine, Walid and Clark, Meredith R and García-Lerma, J Gerardo and Doncel, Gustavo F and Smith, James M},
title = {Extended Postexposure Protection Against Vaginal Simian/Human Immunodeficiency Virus Infection With Tenofovir Alafenamide Fumarate/Elvitegravir Inserts in Macaques},
journal = {The Journal of Infectious Diseases},
year = {2024},
doi = {10.1093/infdis/jiad599}
}
EUVIMED